Researchers develop mathematical measures to better personalize therapy for prostate cancer

Дата публикации: 13-08-2026 12:20:01

Researchers at Moffitt Cancer Center have developed three mathematical biomarkers that may help physicians personalize adaptive therapy for prostate cancer by predicting treatment outcomes early in treatment. The biomarkers are specialized mathematical measures calculated from routine prostate-specific antigen (PSA) blood tests.

Основное содержимое страницы с новостью.

Схожие новости

#	Наименование новости	Тональность	Информативность	Дата публикации
1	Precision therapy for metastatic prostate cancer improves survival	2	7	20-08-2024
2	New urine-based test detects high-grade prostate cancer, helping men avoid unnecessary biopsies	5	7	18-04-2024
3	Blood test distinguishes neuroendocrine subtype of advanced prostate cancer	0	8	10-01-2024
4	For early prostate cancer, 'active surveillance' is now the number 1 choice	0	9.98	13-08-2026
5	Half of prostate cancer focal therapy use found to fall outside current guideline-supported groups	0	7.2	13-08-2026
6	AI digital twin platform advances personalized cancer treatment planning	0	10.93	13-08-2026
7	Cancer-specific c-Myc mapping reveals overlooked SLK protein as treatment target	0	17.95	13-08-2026
8	Scientists uncover drivers of recurrent arthritis after immunotherapy, suggesting potential biomarkers	0	8.62	12-08-2026
9	Blood test may help identify which colorectal cancer patients most likely to benefit from chemotherapy after surgery	0	5	06-07-2026
10	Создан ИИ, способный адаптировать лечение рака под конкретного пациента	7	8	29-06-2026

Классификация: Наука. Схожих патентов: 0. Схожих новостей: 10. Тональность: 0. Информативность: 7.4. Источник: medicalxpress.com.